SEC Form 5 · accession 0001214659-17-000746
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles V Olson
Officer — CHIEF TECHNOLOGY OFFICER
Period of report
Dec 31, 2016
Accepted (ET)
Feb 6, 2017 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2016 | A | 1,789 | $2.63 | A | 9,752 | D | |
| Common Stock | Jan 11, 2017 | A | 7,767 | $0.55 | A | 17,519 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 1,789 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended June 30, 2016.
- F2Represents 7,767 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended December 31, 2016.